Researchers from the Biogerontology Research Foundation , Department of Molecular Neuroscience at the Swammerdam Institute for Life Sciences at the University of Amsterdam, and the Department of Neurobiology, Care Sciences ...
Dec 1, 2017
0
1
Esophageal adenocarcinoma (EA) is an increasingly common cancer that silently affects the esophagus – the muscular tube that moves food into stomach. What causes EA is not well known but gastroesophageal reflux disease ...
Sep 15, 2017
0
0
Researchers at Case Western Reserve University combined finely crafted nanoparticles with one of nature's potent disrupters to prevent the spread of triple-negative breast cancer in mouse models.
May 12, 2015
0
91
A clinical trial of a potential Ebola therapy, led by Oxford University, is underway in Sierra Leone.
Mar 12, 2015
0
4
Researchers from the UNC School of Medicine and colleagues at The University of Texas MD Anderson Cancer Center have developed a new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer. ...
Nov 13, 2014
0
0
To treat the debilitating anemia associated with reduced erythropoietin (EPO) production by the kidneys in chronic renal disease, patients are often given recombinant human EPO to increase hemoglobin levels. But that treatment ...
Oct 16, 2014
0
0
For the first time, researchers at the University of Texas Medical Branch at Galveston, in collaboration with Tekmira Pharmaceuticals, have protected nonhuman primates against Marburg virus – Angola hemorrhagic fever. Their ...
Aug 20, 2014
0
0
Northwestern Medicine scientists have demonstrated that cancer cells – and not normal cells – can be killed by eliminating either the FAS receptor, also known as CD95, or its binding component, CD95 ligand.
Mar 21, 2014
0
0
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs ...
May 22, 2013
0
0
New research suggests that lowering excessive levels of a protein in immune system cells could be a strategy to clear an infection that is deadly to patients with cystic fibrosis (CF).
Jan 23, 2013
0
0
